Lung Cancer Surgery Market: Healthcare Infrastructure and Growth Opportunities 2031

Author : Mikel Watson | Published On : 16 Sep 2026

The Lung Cancer Surgery Market is expected to reach US$8.76 billion by 2031, registering a CAGR of 5.1% during 2025–2031. The market is supported by the increasing burden of lung cancer, growing adoption of minimally invasive surgical techniques, improvements in surgical instruments, and advancements in robotic-assisted procedures. Rising investments in cancer treatment infrastructure and the growing emphasis on early diagnosis and comprehensive cancer care are also contributing to market development.

Lung cancer surgery remains an important treatment approach for eligible patients, particularly those diagnosed at stages where surgical removal of tumors can provide meaningful clinical benefits. Technological developments in thoracic surgery are improving visualization, precision, and procedural efficiency, while minimally invasive approaches are increasingly being incorporated into clinical practice.

What is Driving the Lung Cancer Surgery Market?

The rising incidence of lung cancer is one of the primary factors supporting market growth. Lung cancer remains a major health concern globally, creating sustained demand for diagnostic and therapeutic interventions. As screening and diagnostic capabilities improve, more patients may be identified at stages where surgical intervention can be considered as part of their treatment plan.

The increasing adoption of minimally invasive surgery is another major market driver. Video-assisted thoracoscopic surgery (VATS) and other minimally invasive approaches can provide surgeons with enhanced visualization while potentially reducing surgical trauma compared with traditional open procedures. Growing clinical experience with these techniques is supporting their adoption in appropriate patients.

Technological advancements in surgical equipment are also contributing to market expansion. High-definition visualization systems, advanced surgical instruments, energy devices, and robotic-assisted platforms are increasingly being used to support complex thoracic procedures. These technologies are helping healthcare providers improve precision and procedural control.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006193

Which Region Leads the Lung Cancer Surgery Market?

North America is expected to account for a significant share of the lung cancer surgery market. The region benefits from advanced healthcare infrastructure, established cancer centers, high adoption of minimally invasive and robotic-assisted surgical technologies, and the presence of major medical-device companies.

Europe is another important market, supported by established healthcare systems, increasing focus on cancer diagnosis and treatment, and the adoption of advanced thoracic surgical techniques. Investments in healthcare infrastructure and improvements in cancer-care pathways are expected to support continued demand.

Asia Pacific is expected to offer significant growth opportunities during the forecast period. Increasing healthcare expenditure, expanding hospital infrastructure, rising awareness of cancer screening, and improving access to advanced surgical technologies are contributing to market development. Countries with expanding oncology and thoracic surgery capabilities are expected to create additional opportunities for medical-device manufacturers.

Latin America and the Middle East & Africa are also expected to witness gradual market development as healthcare infrastructure improves and access to specialized cancer treatment expands.

Which Segment Leads the Lung Cancer Surgery Market?

The lung cancer surgery market can be analyzed based on surgery type, procedure, technology, end user, and geography. Minimally invasive procedures are gaining attention due to their potential advantages in recovery and postoperative management. Video-assisted and robotic-assisted techniques are increasingly used for suitable surgical candidates.

By procedure, lobectomy represents an important surgical approach for patients requiring removal of a lung lobe affected by cancer. Other procedures, including wedge resection, segmentectomy, and pneumonectomy, are selected depending on tumor characteristics, disease stage, patient condition, and clinical considerations.

Hospitals and specialized cancer centers represent key end users. These facilities typically have access to advanced surgical equipment, trained thoracic surgeons, multidisciplinary oncology teams, and postoperative care capabilities, making them important contributors to market demand.

Which Companies Are Prominent in the Lung Cancer Surgery Market?

Prominent companies operating in the global lung cancer surgery market include KARL STORZ SE & Co. KG, Olympus Corporation, Ethicon US, LLC (Johnson & Johnson), Accuray Incorporated, Teleflex Incorporated, AngioDynamics, Scanlan International, Intuitive Surgical, TROKAMED GmbH, and Ackermann Instrumente GmbH.

These companies are involved in areas such as surgical visualization, minimally invasive instruments, robotic-assisted surgery, radiation technology, vascular access, and other technologies used throughout cancer treatment. Companies are focusing on product innovation, portfolio expansion, strategic partnerships, and technological development to address the evolving requirements of thoracic surgery.

What is Changing in 2026?

In 2026, the lung cancer surgery market is expected to continue shifting toward minimally invasive, image-guided, and technology-enabled procedures. Healthcare providers are increasingly evaluating technologies that can support surgical precision while improving procedural efficiency and patient recovery.

Robotic-assisted surgery is expected to remain an important area of technological development. Enhanced visualization, instrument articulation, and surgeon control are supporting the use of robotic platforms in selected thoracic procedures.

Another important trend is the increasing integration of surgery with multidisciplinary lung cancer treatment. Treatment planning may involve surgeons, oncologists, radiologists, pulmonologists, and other specialists, supporting more coordinated approaches to patient management.

Advances in imaging and navigation technologies are also expected to influence surgical workflows. Better localization and visualization of pulmonary lesions can support more precise decision-making and procedure planning.

What are the Major Investment Opportunities?

The lung cancer surgery market presents opportunities across robotic surgery, minimally invasive surgical instruments, advanced visualization systems, surgical navigation, and specialized thoracic-care technologies.

Investment in robotic-assisted and image-guided platforms represents an important area of opportunity as hospitals seek to expand their capabilities in minimally invasive surgery. Manufacturers developing instruments designed specifically for thoracic procedures may also benefit from the increasing specialization of surgical techniques.

Emerging markets provide additional opportunities as oncology infrastructure expands and more hospitals acquire advanced surgical equipment. Partnerships between medical-device manufacturers, healthcare institutions, and technology providers can support market expansion and the adoption of innovative solutions.

Related Reports:

Electrotherapy Systems Market Analysis, Size, and Share by 2031

Minimally Invasive Surgery Robot Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

About Us

The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.

Contact US

Contact Person: Ankit Mathur

Phone: +1-646-491-9876

E-mail : [email protected]